Lung Cancer Clinical Trial

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Summary

The purpose of this trial is to study the efficacy and safety of the triplet combination of TLK286, carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 years of age or older
Histologically confirmed non-small cell lung cancer (NSCLC)
Stage IV or IIIB (disease that is not eligible for combined modality chemotherapy and radiation)
Measurable disease by RECIST
ECOG status of 0-1
Adequate liver and renal function
Adequate bone marrow reserves

Exclusion Criteria:

Prior chemotherapy, immunotherapy or biologic therapy for metastatic NSCLC
Up to one prior adjuvant or neoadjuvant chemotherapy is allowed
History of bone marrow transplantation or stem cell support
Pregnant or lactating women

Study is for people with:

Lung Cancer

Phase:

Phase 1

Estimated Enrollment:

100

Study ID:

NCT00088556

Recruitment Status:

Completed

Sponsor:

Telik

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 46 Locations for this study

See Locations Near You

Bay Area Cancer Research Group
Concord California, 94520, United States
East Bay Medical Oncology/Hematology Associates
Concord California, 94520, United States
Southwest Cancer Care
Escondido California, 92025, United States
Kaiser Permanente Medical Center
Hayward California, 94545, United States
Southwest Cancer Care
Murrieta California, 92562, United States
Kaiser Permanente Medical Center
Oakland California, 94611, United States
Southwest Cancer Care
Poway California, 92064, United States
Kaiser Permanente Medical Center
Sacramento California, 95825, United States
Kaiser Permanente Medical Center
San Francisco California, 94115, United States
Kaiser Permanente Medical Center
San Jose California, 95119, United States
Kaiser Permanente Medical Center
Santa Clara California, 95051, United States
Kaiser Permanente Medical Center
So. San Francisco California, 94080, United States
Kaiser Permanente Medical Center
Vallejo California, 94589, United States
Diablo Valley Oncology & Hematology Medical Group
Walnut Creek California, 94520, United States
Kaiser Permanente Medical Center
Walnut Creek California, 94596, United States
Citrus Hematology and Oncology
Crystal River Florida, 34429, United States
Citrus Hematology and Oncology Center
Inverness Florida, 34452, United States
Florida Wellcare Alliance, LC
Inverness Florida, 34452, United States
Kansas City Cancer Center
Kansas City Kansas, 66112, United States
Kansas City Cancer Center - Central Research Dept. Data Office & Drug Discovery Location
Lenexa Kansas, 66214, United States
Kansas City Cancer Center
Overland Park Kansas, 66210, United States
Department of Veterns Affairs - Overton Brooks VA Medical Center
Shreveport Louisiana, 71101, United States
LSU Health Sciences Center
Shreveport Louisiana, 71103, United States
University of Maryland, Baltimore University of Maryland Medical System-Greenebaum Cancer Center
Baltimore Maryland, 21201, United States
Center for Cancer and Blood Disorders, P. C.
Bethesda Maryland, 20817, United States
Massachusetts General Hospital
Boston Massachusetts, 02114, United States
Beth Israel Deaconess Medical Center
Boston Massachusetts, 02115, United States
Brigham & Women's Hospital
Boston Massachusetts, 02115, United States
Dana-Farber Cancer Institute
Boston Massachusetts, 02115, United States
Kansas City Cancer Center
Kansas City Missouri, 64111, United States
Kansas City Cancer Center
Kansas City Missouri, 64131, United States
Kansas City Cancer Center
Kansas City Missouri, 64154, United States
Kansas City Cancer Center
Lee's Summit Missouri, 64064, United States
St. John's Mercy Medical Center
St. Louis Missouri, 63141, United States
St. John's Mercy Hospital
Washington Missouri, 63090, United States
Clinical Research Service
Scottsbluff Nebraska, 69361, United States
Horizons West Medical Group
Scottsbluff Nebraska, 69361, United States
Dakota Cancer Institute
Fargo North Dakota, 58103, United States
Odyssey Research
Fargo North Dakota, 58104, United States
Tennessee Oncology, PLLC
Clarksville Tennessee, 37043, United States
Tennessee Oncology, PLLC
Franklin Tennessee, 37067, United States
Tennessee Oncology, PLLC
Hermitage Tennessee, 37076, United States
Tennessee Oncology, PLLC
Lebanon Tennessee, 37087, United States
Tennessee Oncology, PLLC
Murfreesboro Tennessee, 37130, United States
Tennessee Oncology, PLLC
Nashville Tennessee, 37203, United States
Tennessee Oncology, PLLC
Nashville Tennessee, 37205, United States
Tennessee Oncology, PLLC
Nashville Tennessee, 37207, United States
Tennessee Oncology, PLLC
Nashville Tennessee, 37211, United States
Tennessee Oncology, PLLC
Smyrna Tennessee, 37167, United States
Texas Cancer Associates
Dallas Texas, 75231, United States
Texas Cancer Associates
Plano Texas, 75093, United States
Danville Hematology & Oncology, Inc.
Danville Virginia, 24541, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 1

Estimated Enrollment:

100

Study ID:

NCT00088556

Recruitment Status:

Completed

Sponsor:


Telik

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider